Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Launched by HENAN CANCER HOSPITAL · Oct 24, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the long-term effects of anxiety and depression in patients who have malignant tumors, which are cancerous growths. The researchers want to understand how these emotional challenges affect patients over time. They are currently looking for men and women of all ages who have been diagnosed with a malignant tumor at their hospital and have been hospitalized at least once for treatment. To participate, patients should expect to have a good chance of living for more than a year.

If you decide to join this study, you'll be asked to provide basic information about your health, along with details about any anxiety or depression you might be experiencing. This research is important because it aims to improve the understanding of how emotional well-being impacts cancer treatment and recovery. The study is still recruiting participants, so if you think you might be eligible, it could be a great opportunity to contribute to important research while receiving support for your mental health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Men and women of all ages are welcome.
• • 2. Pathological diagnosis of malignant tumor in our hospital.
• • 3. Received at least one hospitalization at this hospital.
• • 4. The expected survival time is greater than 1 year.
• Exclusion Criteria:
• • 1.There was no pathological report of malignancy.